3,676
Views
90
CrossRef citations to date
0
Altmetric
REVIEW ARTICLE

Stanford-A acute aortic dissection, inflammation, and metalloproteinases: A review

, , , , , & show all
Pages 441-446 | Received 23 Mar 2015, Accepted 07 Jul 2015, Published online: 28 Aug 2015

References

  • Isselbacher EM. Thoracic and abdominal aortic aneurysms. Circulation. 2005;111:816–28.
  • Tsai TT, Nienaber CH, Eagle KA. Acute aortic syndromes. Circulation. 2005;112:3802–13.
  • Taylor PR, Jacobs PR, Jacobs MJHM. Thoracic and thoraco-abdominal aortic aneurysms, dissections and acute aortic syndrome. In: Beard JD, Gaines PA, editors. Vascular and endovascular surgery. Philadelphia, PA: Elsevier Limited; 2006. p. 249–56.
  • Hagan PG. The international registry of acute aortic dissection (IRAD): new insights into an old disease. JAMA. 2000;283:897–903.
  • Didangelos A, Yin X, Mandal K, Saje A, Smith A, Xu Q, et al. Extracellular matrix composition and remodelling in human abdominal aortic aneurysms: a proteomics approach. Mol Cell Proteomics. 2011;10: M111.008128.
  • Ramanath VS, Stundt T, Eagle KA. Acute aortic syndromes and thoracic aortic aneurysm. Mayo Clin Proc. 2009;84:465–81.
  • Sakalihasan N, Limet R, Defawe OD. Abdominal aortic aneurysm. Lancet. 2005;365:1577–89.
  • Manabe T, Imoto K, Uchida K, Doi C, Takanashi Y. Decreased tissue inhibitor of metalloproteinase-2/matrix metalloproteinases ratio in the acute phase of aortic dissection. Surg Today. 2004;34:220–5.
  • Koullias GJ, Ravichandran P, Korkolis DP, Rimm DL, Elefteriades JA. Increased tissue microarray matrix metalloproteinase expression favors proteolysis in thoracic aortic aneurysms and dissections. Ann Thorac Surg. 2004;78:2106–10.
  • Ikonomidis JS, Jones JA, Barbour JR , Stroud RE, Clark LL, Kaplan BS, et al. Expression of matrix metalloproteinases and endogenous inhibitors within ascending aortic aneurysms of patients with Marfan syndrome. Circulation. 2006;114(Suppl 1):365–70.
  • Sangiorgi G, Trimarchi S, Mauriello A, Righini P, Bossone E, Suzuki T, et al. Plasma levels of metalloproteinases-9 and -2 in the acute and subacute phases of type A and type B aortic dissection. J Cardiovasc Med (Hagerstown). 2006;7:307–15.
  • Patel MI, Melrose J, Ghosh P, Appleberg M. Increased synthesis of marix metalloproteinases by aortic smooth cell is implicated in the etiopathogenesis of abdominal aortic aneurysms. J Vasc Surg. 1996;24:82–92.
  • Luo F, Zhou XL, Li YY, Hui RT. Inflammatory response is associated with aortic dissection. Ageing Res Rev. 2009;8:31–5.
  • He R, Guo DG, Estrera AL, Safi HJ, Huynh TT, Yin Z, et al. Characterization of the inflammatory and apoptotic cells in the aortas of patients with ascending thoracic aortic aneurysms and dissections. J Thorac Cardiovasc Surg. 2006;131:671–8.
  • Del Porto F, Proietta M, Tritapepe L, Miraldi F, Koverech A, Cardelli P, et al. Inflammation and immune response in acute aortic dissection. Ann Med. 2010;42:622–9.
  • Del Porto F, di Gioia C, Tritapepe L, Ferri L, Leopizzi M, Nofroni I, et al. The multitasking role of macrophages in Stanford A acute aortic dissection. Cardiology. 2014;127:123–9.
  • Hansson GK. Inflammation, atherosclerosis and coronary artery disease. N Engl J Med. 2005;352:1685–95.
  • Charo IF, Ransohoff RM. The many role chemokines and chemokine receptors in inflammation. N Engl J Med. 2006;354:610–21.
  • Shimizu K, Shichiri M, Libby P, Lee RT, Mitchell R. Th-2 predominant inflammation and blockade of IFN-γ signalling induce aneurysms in allografted aortas. J Clin Invest. 2004;114:300–8.
  • Saraff K, Babamusta K, Cassis LA, Daugherty A. Aortic dissection precedes formation of aneurysms and atherosclerosis in angiotensin II-infused, apolipoprotein E- deficient mice. Arterioscler Thromb Vasc Biol. 2003;23:1621–6.
  • He R, Guo DC, Sun W, Papke CL, Duraisamy S, Estrera AL, et al. Characterization of the inflammatory cells in ascending thoracic aortic aneurysms in patients with Marfan syndrome, familial thoracic aortic aneurysms and sporadic aneurysms. J Thorac Cardiovasc Surg. 2008;134:922–9.
  • Weis-Muller BT, Modlich O, Drobinskaya I, Unay D, Huber R, Bojar H, et al. Gene expression in acute Stanford type A dissection: a comparative microarray study. J Transl Med. 2006;4:29–44.
  • Guo G, Gehle P, Martin-Ventura JL, von Kodolitsch Y, Hetzer R, Robinson PN. Induction of macrophage chemotaxis by aortic extracts from patients with Marfan syndrome is related to elastin binding protein. PLoS One. 2011;6:e20138.
  • Hahn AW, Jonas U, Bühler FR, Resink TJ. Activation of human peripheral monocytes by angiotensin II. FEBS Lett. 1994;347:178–80.
  • Guo F, Chen XL, Wang F, Liang X, Sun YX, Wang YJ. Role of angiotensin II type 1 receptor in angiotensin II-induced cytokine production in macrophages. J Interferon Cytokine Res. 2011;31:351–61.
  • Walter A, Etienne-Sellum N, Sarr M, Kane MO, Beretz A, Schini-Kerth VB. Angiotenis II induces the vascular expression of VEGF and MMP-2 in vivo: preventive effect of red wine polyphenolis. J Vasc Res. 2008;45:386–94.
  • Wang R, Chen W, Ma Z, Li L, Chen X. M1/M2 macrophages and associated mechanisms in congenital bicuspid aortic valve stenosis. Exp Ther Med. 2014;7:935–40.
  • Lindeman JH, Abdul-Hussein H, Schaapherder AF, Van Bockel JH, Von der Thüsen JH, Roelen DL, et al. Enhanced expression and activation of pro-inflammatory transcription factors distinguish aneurysmal from atherosclerotic aorta: IL-6 and IL-8 dominated inflammatory responses prevail in the human aneurysms. Clin Sci (Lond). 2008;114:687–97.
  • Tieu BC, Lee C, Sun H, Lejeune W, Recinos A 3rd, Ju X, et al. An adventitial IL-6/MCP1 amplification loop accelerates macrophage-mediated vascular inflammation leading to aortic dissection in mice. J Clin Invest. 2009;119:3637–51.
  • Ju X, Ljaz T, Sun H, Lejeune W, Vargas G, Shilagard T, et al. IL-6 regulates extracellular matrix remodelling associated with aortic dilation in a fibrillin-1 hypomorphic mgR/mgR mouse model of severe Marfan syndrome. J Am Heart Assoc. 2014;3:e000476.
  • Longo GM, Buda SJ, Fiotta N, Xiong W, Griener T, Shapiro S, et al. MMP-12 has a role in abdominal aortic aneurysms in mice. Surgery. 2005;137:457–62.
  • Proietta M, Tritapepe L, Cifani N, Ferri L, Taurino M, Del Porto F. MMP-12 as a new marker of Stanford-A acute aortic dissection. Ann Med. 2014;46:44–8.
  • Edwards DR, Handsley MM, Pennington CJ. The ADAM metalloproteinases. Mol Aspects Med. 2008;29:258e89.
  • Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res. 2003;92:827–39.
  • Khokha R, Murthy A, Weiss A. Metalloproteinases and their natural inhibitors in inflammation and immunity. Nat Rev Immunol. 2013;13:649–65.
  • Nissinen L, Kahari VM. Matrix metalloproteinases in inflammation. Biochim Biophys Acta. 2014;1840:2571–80.
  • Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol. 2001;17:463–516.
  • Overall CM, McQuibban GA, Clark-Lewis I. Discovery of chemokine substrates for matrix metalloproteinases by exosite scanning: a new tool for degradomics. Biol Chem. 2002;383:1059–66.
  • Giannandrea M, Parks WC. Diverse functions of matrix metalloproteinases during fibrosis. Diverse functions of matrix metalloproteinases during fibrosis. Dis Mod Mech. 2014;7:193–203.
  • Newby AC. Metalloproteinase expression in monocyte and macrophages and its relationship to atherosclerotic plaque instability. Atheroscler Thromb Vasc Biol. 2008;28:2108–14.
  • Zhang X, Wu D, Choi JC, Minard CG, Hou X, Coselli JS, et al. Matrix metalloproteinase levels in chronic thoracic aortic dissection. J Surg Res. 2014;189:348–58.
  • Ravn HB, Falk E. Histopathology of plaque rupture. Cardiol Clin. 1999;17:263–70.
  • McQuibban GA, Butler GS, Gong JH, Bendall L, Power C, Clark-Lewis I, et al. Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1. J Biol Chem. 2001;276:43503–8.
  • McQuibban GA, Gong JH, Wong JP, Wallace JL, Clark-Lewis I, Overall CM. Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo. Blood. 2002;100:1160–7.
  • Houghton AM, Hartzell WO, Robbins CS, Gomis-Rüth FX, Shapiro SD. Macrophage elastase kills bacteria within murine macrophages. Nature. 2009;460:637–41.
  • Gu Y, Lee HM, Sorsa T, Salminen A, Ryan ME, Slepian MJ, et al. Non-antibacterial tetracyclines modulate mediators of periodontitis and atherosclerotic cardiovascular disease: a mechanistic link between local and systemic inflammation. Pharmacol Res. 2011;64:573–9.
  • Sorsa T, Tervahartiala T, Leppilahti J, Hernandez M, Gamonal J, Tuomainen AM, et al. Collagenase-2 (MMP-8) as a point-of-care biomarker in periodontitis and cardiovascular diseases. Therapeutic response to non-antimicrobial properties of tetracyclines. Pharmacol Res. 2011;63:108–13.
  • Sorsa T, Tjäderhane L, Konttinen YT, Lauhio A, Salo T, Lee HM, et al. Matrix metalloproteinases: contribution to pathogenesis, diagnosis and treatment of periodontal inflammation. Ann Med. 2006;38:306–21.
  • Murphy G. The ADAMs: signalling scissors in the tumour microenvironment. Nat Rev Cancer. 2008;8:929e41.
  • Porter S, Clark IM, Kevorkian L, Edwards DR. The ADAMTS metalloproteinases. Biochem J. 2005;386:15–27.
  • Jonsson-Rylander AC, Nilsson T, Fritsche-Danielson R, Hammarström A, Behrendt M, Andersson JO, et al. Role of ADAMTS-1 in atherosclerosis: remodelling of carotid artery, immunohistochemistry, and proteolysis of versican. Arterioscler Thromb Vasc Biol. 2005;25:180–5.
  • Wagsater D, Bjork H, Zhu C, Björkegren J, Valen G, Hamsten A, et al. ADAMTS-4 and -8 are inflammatory regulated enzymes expressed in macrophage-rich areas of human atherosclerotic plaques. Atherosclerosis. 2008;196:514–22.
  • Taketani T, Imai Y, Morota T, Maemura K, Morita H, Hayashi D, et al. Altered patterns of gene expression specific to thoracic aortic aneurysms: microarray analysis of surgically resected specimens. Int Heart J. 2005;46:265–77.
  • Ren P, Zhang L, Xu G, Palmero LC, Albini PT, Coselli JS, et al. ADAMTS-1 and ADAMTS-4 levels are elevated in thoracic aortic aneurysms and dissections. Ann Thorac Surg. 2013;95:570–7.
  • Levula M, Paavonen T, Valo T, Pelto-Huikko M, Laaksonen R, Kahonen M, et al. A disintegrin and metalloprotease -8 and -15 and susceptibility for ascending aortic dissection. Scand J Clin Lab Invest. 2011;71:515–22.
  • Rabkin SW. Differential expression of MMP-2, MMP-9 and TIMP proteins in thoracic aortic aneurysm- comparison with and without bicuspid aortic valve: a meta analysis. Vasa. 2014;43:433–42.
  • Xiong W, Meisinger T, Knispel R, Worth JM, Baxter BT. MMP-2 regulates Erk1/2 phosphorylation and aortic dilatation in Marfan syndrome. Circ Res. 2012;110:e92–e101.
  • Karapanagiotidis GT, Antonitsis P, Charokopos N, Foroulis CN, Anastasiadis K, Rouska E, et al. Serum levels of matrix metalloproteinases -1,-2,-3 and -9 in thoracic aortic diseases and acute myocardial ischemia. J Cardiothorac Surg. 2009;4:59–66.
  • Svensson LG, Crawford ES. Aortic dissection and aortic aneurysm surgery: clinical observations, experimental investigations and statistical analyses, Part II. Curr Probl Surg. 1992;29:913–1057.
  • Agg B, Benke K, Szilveszter B, et al. Possible extracardiac predictors of aortic dissection in Marfan syndrome. BMC Cardiovasc Disord. 2014;14:47.
  • Song Y, Xie Y, Liu F, Zhao C, Yu R, Ban S, et al. Expression of matrix metalloproteinase-12 in aortic dissection. BMC Cardiovasc Disord. 2013;13:34.
  • Matsumoto S, Kobayashi T, Katoh M, Saito S, Ikeda Y, Kobori M, et al. Expression and localization of matrix metalloproteinase-12 in the aorta of cholesterol-fed rabbits. Am J Pathol. 1998;153:109–19.
  • Schneiderman J, Bordin GM, Adar R, Smolinsky A, Seiffert D, Engelberg I, et al. Patterns of expression of fibrinolytic genes and matrix metalloproteinase-9 in dissecting aortic aneurysms. Am J Pathol. 1998;152:703–10.
  • Wen T, Liu L, Xiong GZ. Matrix metalloproteinase levels in acute aortic dissection, acute pancreatitis and other abdominal pain. Emerg Med J. 2009;10:715–18.
  • Li Y, Shao AZ, Jiang HT, Dong GH, Xu B, Yi J, et al. The prominent expression of plasma matrix metalloproteinase-8 in acute thoracic aortic dissection. J Surg Res. 2010;163:99–104.
  • Kurihara T, Shimizu-Hirota R, Shimoda M, Adachi T, Shimizu H, Weiss SJ, et al. Neutrophil-derived matrix metalloproteinase 9 triggers acute aortic dissection. Circulation. 2012;123:3070–80.
  • Busti C, Falcinelli E, Momi S, Gresele P. Matrix metalloproteinases and peripheral arterial disease. Int Emerg Med. 2010;5:13–25.
  • Chandler S, Cossins J, Lury J, Wells G. Macrophage metalloelastase degrades matrix and myelin proteins and processes a tumour necrosis factor-alpha fusion protein. Biochem Biophys Res Commun. 1996;228:421–9.
  • Gronski TJ, Martin RL, Kobayashi DK, Walsh BC, Holman MC, Huber M, et al. Hydrolysis of a broad spectrum of extracellular matrix proteins by human macrophage elastase. J Biol Chem. 1997;272:12189–94.
  • Curci JA, Liao S, Huffman MD, Shapiro SD, Thompson RW. Expression and localization of macrophage elastase (matrix metalloproteinase -12) in abdominal aortic aneurysms. J Clin Invest. 1998;102:1900–10.
  • Chae CU, Lee RT, Rifai N, Ridker PM. Blood pressure and inflammation in apparently healthy men. Hypertension. 2001;38:399–403.
  • Schulz E, Gori T, Münzel T. Oxidative stress and endothelial dysfunction in hypertension. Hypertens Res. 2011;34:665–73.
  • Stumpf C, Jukic J, Yilmaz A, Raaz D, Schmieder RE, Daniel WG, et al. Elevated VEGF-plasma levels in young patients with mild essential hypertension. Eur J Clin Invest. 2009;39:31–6.
  • Cheng XW, Song H, Sasaki T, Hu L, Inoue A, Bando YK, et al. Angiotensin type 1 receptor blocker reduces intimal neovascularizzation and plaque growth in apolipoprotein E-deficient mice. Hypertension. 2011;57:981–9.
  • Habashi JP, Doyle JJ, Holm TM, Aziz H, Schoenhoff F, Bedja D, et al. Angiotensin II type receptor signalling attenuates aortic aneurysm in mice throughout ERK antagonism. Science. 2011;332:361–5.
  • Wang Y, Ait-Oufella H, Herbin O, Bonnin P, Ramkhelawon B, Taleb S, et al. TGF-beta activity protects against inflammatory aortic aneurysm progression and complications in angiotensin II-infused mice. Clin Invest. 2010;120:422–32.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.